What is the recommended management for an adult male with localized squamous cell carcinoma of the penis?

Management of Localized Squamous Cell Carcinoma of the Penis

For localized penile squamous cell carcinoma, treatment should be stratified by tumor stage and grade: penile-preserving techniques (wide local excision, laser therapy, or topical therapy) are recommended for Tis/Ta and T1G1-2 lesions, while partial or total penectomy is required for T1G3-4 and T≥2 tumors. 1

Initial Evaluation

Before determining treatment, obtain the following:

• Histologic diagnosis via punch, excisional, or incisional biopsy to determine tumor grade and stage 1
• Physical examination documenting: lesion diameter, exact anatomic location (glans, prepuce, shaft), number of lesions, morphology (papillary, nodular, ulcerous, or flat), and relationship to deeper structures (corpora spongiosa, corpora cavernosa, urethra) 1
• MRI or ultrasound (optional) to evaluate depth of tumor invasion 1
• Assessment for lymphovascular invasion, perineural invasion, and tumor differentiation, as these are the strongest predictors of lymph node metastasis 1

Treatment Algorithm by Stage and Grade

Tis or Ta (Carcinoma in Situ or Noninvasive Verrucous Carcinoma)

Penile-preserving techniques are the standard of care 1:

• Topical therapy: 5-fluorouracil cream or imiquimod 5% 1, 2
• Wide local excision including circumcision or Mohs surgery 1
• Laser therapy (category 2B): CO2 or Nd:YAG laser with ~18% local recurrence rate, comparable to surgery with superior cosmetic outcomes 1, 2
• Complete glansectomy (category 2B) for refractory cases 1

For erythroplasia of Queyrat specifically, topical 5-fluorouracil or imiquimod are first-line, with CO2 laser ablation as an excellent alternative offering superior cosmetic and functional preservation 2

T1, G1-2 (Low-Grade Invasive Disease)

Penile-preserving surgery is recommended for reliable patients who can comply with close follow-up 1:

• Wide local excision with 5-10 mm surgical margins (as safe as traditional 2-cm margins) 1, 3
• Mohs surgery as an option with reconstructive surgery 1
• Laser therapy (category 2B) 1
• Radiotherapy (category 2B): external beam or brachytherapy, but circumcision must precede radiation to prevent complications 1

Critical caveat: Local recurrence rates may reach 50% at 2 years, making intensive surveillance mandatory 1. However, T1 well-differentiated tumors show 10% local recurrence with penile-conserving therapy, and all recurrences are salvageable 4

T1, G3-4 or T≥2 (High-Grade or Advanced Disease)

Partial or total penectomy is required 1:

• Partial penectomy for lesions that allow adequate margins while preserving functional penile length 1, 5
• Total penectomy for extensive disease involving the penile shaft or base 1, 5
• Surgical margins of 5-10 mm are adequate for local control; the traditional 15-25 mm margins are unnecessary 1, 3

Stage T3 tumors (urethral invasion) should not be treated with penile-conserving approaches, as all T3 tumors treated with external radiation in one series experienced local failure 4

Lymph Node Management

Risk stratification determines lymph node evaluation 1:

• Low-risk (Tis, Ta, T1G1): No lymph node assessment needed 1
• Intermediate-risk (T1G2): 13-29% develop lymph node metastases; consider dynamic sentinel node biopsy or modified inguinal lymphadenectomy 1
• High-risk (T1G3, T≥2, lymphovascular invasion, perineural invasion): Inguinal lymph node evaluation mandatory 1

Important: 30-50% of palpable inguinal lymphadenopathy is inflammatory rather than malignant, requiring 6-week antibiotic trial or fine-needle aspiration before definitive intervention 6

Follow-Up Protocol

Patients treated with penile-preserving therapy require intensive surveillance 2:

• Every 3-6 months for the first 2-3 years 2
• Every 6-12 months thereafter, as 92% of recurrences occur within 5 years 2
• Biopsy any suspicious lesions immediately to distinguish recurrence from inflammatory changes 2

Critical Pitfalls to Avoid

• Do not delay diagnosis with prolonged topical corticosteroid trials; a case report documented invasive SCC treated with antifungals and corticosteroids for 2 years, necessitating partial glansectomy 7
• Do not perform penile-conserving surgery on poorly differentiated T2 tumors or any T3 tumors, as local failure rates are unacceptably high 4
• Do not assume palpable inguinal nodes are metastatic; inflammatory adenopathy is common and requires confirmation before lymphadenectomy 6
• Circumcision must precede radiotherapy to prevent radiation-related complications 1

Prognosis

Nodal involvement is the most important prognostic factor: 5-year survival exceeds 85% with negative lymph nodes but drops to 29-40% with positive nodes and 0% with pelvic lymph node involvement 1